| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/13/2011 | WO2010111657A3 System, method and computer-accessible medium for determining membrane properties relating to diffusion |
| 01/13/2011 | WO2010111219A3 Site localization and methods for monitoring treatment of disturbed blood vessels |
| 01/13/2011 | WO2010108095A3 Microfluidic cell motility assay |
| 01/13/2011 | WO2010108042A3 Non-coherent light microscopy |
| 01/13/2011 | WO2010108038A3 A microscopy system and method for creating three dimensional images using probe molecules |
| 01/13/2011 | WO2010107893A3 Method and test kit for the determination of iron content of in-use lubricants |
| 01/13/2011 | WO2010107667A3 Evaluating renal function |
| 01/13/2011 | WO2010107654A3 Split flow device for analyses of specific-binding partners |
| 01/13/2011 | WO2010105197A3 Non-contact optical system, computer-accessible medium and method for measuring at least one mechanical property of tissue using coherent speckle techniques(s) |
| 01/13/2011 | WO2010104993A3 Fluidic flow cytometry devices and particle sensing based on signal-encoding |
| 01/13/2011 | WO2010104981A3 Deuterium isobaric tag reagents for quantitative analysis |
| 01/13/2011 | WO2010104937A3 Lateral flow strip and uses thereof |
| 01/13/2011 | WO2010104856A3 Devices and methods for contactless dielectrophoresis for cell or particle manipulation |
| 01/13/2011 | WO2010102310A3 Systems, methods, and devices having stretchable integrated circuitry for sensing and delivering therapy |
| 01/13/2011 | WO2010102277A3 Methods of diagnosing and treating prostate cancer characterized by ndrg1-erg fusion |
| 01/13/2011 | WO2010102215A3 Automated placental measurement |
| 01/13/2011 | WO2010102195A3 Annexin a11 and associated genes as biomarkers for cancer |
| 01/13/2011 | WO2010102160A3 Diagnostic method using palb2 |
| 01/13/2011 | WO2010101947A3 Rapid oligo probes |
| 01/13/2011 | WO2010099510A3 Amino acid-based compounds, their methods of use, and methods of screening |
| 01/13/2011 | WO2010099169A3 A novel in vitro hiv-1 latency model for screening reactivation agents of hiv-1 |
| 01/13/2011 | WO2010094427A3 Compact storage of auxiliary analytical devices in a cartridge |
| 01/13/2011 | WO2010079490A8 Detection of cancer through breath comprising a sensor array comprising capped conductive nanoparticles |
| 01/13/2011 | WO2010077894A3 Methods of inhibiting quiescent tumor proliferation |
| 01/13/2011 | WO2010063832A8 Methods for testing binding of a ligand to a g protein-coupled receptor |
| 01/13/2011 | WO2010019550A4 Method of identifying disease risk factors |
| 01/13/2011 | WO2009141151A3 Device for receiving a solid in a measuring cell |
| 01/13/2011 | WO2009140684A3 Use of biomarkers for assessing treatment of gastrointestinal inflammatory disorders with beta7integrin antagonists |
| 01/13/2011 | US20110010780 Kcnn3 as diagnostic and therapeutic target for neurodegenerative diseases |
| 01/13/2011 | US20110010104 Methods and systems for detecting the hydration of sensors |
| 01/13/2011 | US20110010103 Rapid method of pattern recognition, machine learning, and automated genotype classification through correlation analysis of dynamic signals |
| 01/13/2011 | US20110010102 Methods and Systems for Sequence-Directed Molecular Breeding |
| 01/13/2011 | US20110010100 Functional domain analysis method and system |
| 01/13/2011 | US20110010099 Correlation Analysis of Biological Systems |
| 01/13/2011 | US20110009986 System and method for dynamically controlling odor emission |
| 01/13/2011 | US20110009861 Predicting atrial fibrillation recurrence by protease and protease inhibitor profiling |
| 01/13/2011 | US20110009474 Sirtuin based methods and compositions for treating beta-catenin-related conditions |
| 01/13/2011 | US20110009471 Oligonucleotide analogues and methods utilizing the same |
| 01/13/2011 | US20110009469 Compositions and methods of treating neoplasia |
| 01/13/2011 | US20110009467 Methods to Increase or Decrease Bone Density |
| 01/13/2011 | US20110009408 Methods for identifiying inhibitors against viruses that use a class i fusion protein |
| 01/13/2011 | US20110009387 Histone h2ax (hh2ax) biomarker for fti sensitivity |
| 01/13/2011 | US20110009386 Furo[3, 2-b] pyrr0l-3-0nes as cathespin s inhibitors |
| 01/13/2011 | US20110009385 Compounds |
| 01/13/2011 | US20110009361 Design and selection of medicaments that modulate the function and activity of interleukin 13 |
| 01/13/2011 | US20110009292 Attachment of molecules to surfaces |
| 01/13/2011 | US20110009289 Methods of using an array of pooled probes in genetic analysis |
| 01/13/2011 | US20110009285 Method of diagnosing a progressive disease |
| 01/13/2011 | US20110009284 Gene relating to estimation of postoperative prognosis for breast cancer |
| 01/13/2011 | US20110009283 Identification of toxin ligands |
| 01/13/2011 | US20110009279 Methods of Diagnosing Non-Alcoholic Steatohepatitis (NASH) |
| 01/13/2011 | US20110009277 Method for methylation analysis |
| 01/13/2011 | US20110008914 Biomarkers for the Diagnosis and Treatment of Pancreatic Cancer |
| 01/13/2011 | US20110008913 Tumor suppressor gene |
| 01/13/2011 | US20110008912 Polymer-coated substrates for binding biomolecules and methods of making and using Thereof |
| 01/13/2011 | US20110008911 Diagnostic method for disorders using copeptin |
| 01/13/2011 | US20110008910 Method for the immobilization of a capture molecule on a solid support |
| 01/13/2011 | US20110008909 Assay Device |
| 01/13/2011 | US20110008908 Apparatus and method for separating and analyzing blood |
| 01/13/2011 | US20110008907 System using self-contained processing module for detecting nucleic acids |
| 01/13/2011 | US20110008906 Genetic Association of Polymorphisms in Perilipin (PLIN) Gene With Resistance to Weight Loss |
| 01/13/2011 | US20110008905 System for detecting polynucleotides |
| 01/13/2011 | US20110008904 Method for determining if a patient has a traumatic brain injury and related apparatus |
| 01/13/2011 | US20110008903 Methods and kits for determining the occurrence of a liver disease in a subject |
| 01/13/2011 | US20110008902 Method and device for studying transport of an agent across a bilayer membrane in bioanalytical sensor applications |
| 01/13/2011 | US20110008901 Apolipoprotein ciii in pre- and type 2 diabetes |
| 01/13/2011 | US20110008900 Depletion of plasma proteins |
| 01/13/2011 | US20110008899 Apparatus for determining the composition of a specimen, in particular one containing protein |
| 01/13/2011 | US20110008898 Method for Simply Quantitatively Determining Hexavalent Chromium Technical Field |
| 01/13/2011 | US20110008879 Bio-assay substrate, bio-assay apparatus, and reading apparatus |
| 01/13/2011 | US20110008869 Engineered proteases for affinity purification and processing of fusion proteins |
| 01/13/2011 | US20110008840 Anti-cd33 antibodies and methods for treatment of acute myeloid leukemia using the same |
| 01/13/2011 | US20110008827 Method to produce recombinant MBP8298 and other polypeptides by nucleotide structure optimization |
| 01/13/2011 | US20110008813 Assay device and method |
| 01/13/2011 | US20110008812 Methods and substances for the diagnosis and therapy of sepsis and sepsis-like systemic infections |
| 01/13/2011 | US20110008811 Resin Assisted Capture of Cysteine-Modified Proteins/Peptides and Determination of Presence and Location of Modification |
| 01/13/2011 | US20110008808 Biomarkers |
| 01/13/2011 | US20110008807 Composition Related to Rapid ELISA Process |
| 01/13/2011 | US20110008806 Method and kit for quantifying of allergen-specific human igg subclasses for the control and attendance of specific immunotherapy |
| 01/13/2011 | US20110008805 Markers Associate with Arteriovascular Events and Methods of Use Thereof |
| 01/13/2011 | US20110008804 Angiopoietin-1 and -2 biomarkers for infectious diseases that compromise endothelial integrity |
| 01/13/2011 | US20110008803 Assays for non-apoptotic cell death and uses thereof |
| 01/13/2011 | US20110008802 TNFalpha GENE EXPRESSION AS A BIOMARKER OF SENSITIVITY TO ANTAGONISTS OF INHIBITOR OF APOPTOSIS PROTEINS |
| 01/13/2011 | US20110008801 Methods for measuring cell-cell or cell-matrix adhesive forces and compounds for disrupting adhesive forces in biological systems |
| 01/13/2011 | US20110008800 Crystal structure of cmy-10, a beta-lactamase causing antibiotic resistance with extended-substrate spectrum |
| 01/13/2011 | US20110008799 Phenotypic ratio of serum amyloid in pre- and type 2 diabetes |
| 01/13/2011 | US20110008798 Lipid insertion for antigen capture and presentation and use as a sensor platform |
| 01/13/2011 | US20110008796 Industrial method for the encapsulation of biological material for the purpose of storage at ambient temperature with a vacuum seal test of the encapsulation |
| 01/13/2011 | US20110008789 Methods and materials for treating inflammatory conditions |
| 01/13/2011 | US20110008786 Methods of detecting and controlling mucoid pseudomonas biofilm production |
| 01/13/2011 | US20110008785 Methods for forensic dna quantitation |
| 01/13/2011 | US20110008783 Fluorimetric process for evaluating the influence of a condition on a biological sample, and applications thereof |
| 01/13/2011 | US20110008776 Integrated separation and detection cartridge using magnetic particles with bimodal size distribution |
| 01/13/2011 | US20110008769 Dopaminergic neuron progenitor cell marker 187a5 |
| 01/13/2011 | US20110008766 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 01/13/2011 | US20110008765 Use of three-dimensional microfabricated tissue engineered systems for pharmacologic applications |
| 01/13/2011 | US20110008523 Genetic sequences having methyltransferase activity and uses therefor |
| 01/13/2011 | US20110008502 Processed food composition containing dextrin |
| 01/13/2011 | US20110008498 Methods and Compositions for Preparing Consumables with Optical Shifting Properties |
| 01/13/2011 | US20110008467 Sodium thiosulfate-containing pharmaceutical compositions |